Gemtuzumab ozogamicin: is there room for salvage?

Blood. 2010 Oct 7;116(14):2618-9. doi: 10.1182/blood-2010-08-300871.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aminoglycosides / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Gemtuzumab
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • United States
  • United States Food and Drug Administration

Substances

  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Gemtuzumab